Today
+6.51%
5 Days
+13.76%
1 Month
-12.66%
6 Months
+37.23%
Year to Date
-2.71%
1 Year
-38.12%
• CVS Health launched new GLP-1 weight management services and virtual consultation programs. • Financial analysts raised price targets following the company's strategic expansion into GLP-1 markets. • CVS reported improved quarterly earnings and updated guidance amid ongoing operational restructuring efforts.
• CVS Health price increased due to analyst upgrades and strong earnings. • Q1 2026 earnings surpassed expectations, with raised full-year guidance. • Stock shows mixed signals from valuation and insider selling.
• HCA Healthcare Q1 2026 results missed adjusted EBITDA expectations. • Company reaffirmed 2026 guidance, disappointing some investors. • Lower patient admissions and surgeries impacted operational performance.
• Analyst price target reductions pressured Intuitive Surgical stock. • FDA alerts and recalls on stapling devices created regulatory concerns. • Company guidance projected slower procedure growth and tariff impacts.
• Abbott's Q1 earnings and revenue exceeded expectations. • Full-year earnings guidance was lowered due to Exact Sciences acquisition. • Regulatory scrutiny and Nutrition segment decline pressured stock.
• UnitedHealth Group Q1 2026 revenue exceeded expectations at $111.7 billion. • Medical care ratio improved to 83.9%, and full-year EPS outlook raised. • CMS 2027 Medicare Advantage rate increase provides significant tailwind.


| Shareholders | Proportion |
|---|---|
| BlackRock Institutional Trust Company, N.A. | 10.38% |
| JP Morgan Asset Management | 6.72% |
| Capital World Investors | 6.42% |
| Vanguard Portfolio Management, LLC | 4.57% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 49.41% |
| Investment Advisor/Hedge Fund | 12.84% |
| Research Firm | 10.91% |
| Hedge Fund | 6.28% |
Related Instruments
Popular Instruments